Janus Henderson Group
MRVI icon

Janus Henderson Group’s Maravai LifeSciences MRVI Stock Holding History

Janus Henderson Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-48,498
Closed -$114K – 2476
2025
Q1 		$114K Hold
48,498
– – ﹤0.01% 2450
2024
Q4 		$264K Hold
48,498
– – ﹤0.01% 2309
2024
Q3 		$403K Hold
48,498
– – ﹤0.01% 2136
2024
Q2 		$348K Sell
48,498
-565
-1% -$4.88K ﹤0.01% 2140
2024
Q1 		$425K Sell
49,063
-408,709
-89% -$2.77M ﹤0.01% 2083
2023
Q4 		$3M Sell
457,772
-42,595
-9% -$275K ﹤0.01% 1044
2023
Q3 		$5M Buy
500,367
+124,055
+33% +$1.36M ﹤0.01% 816
2023
Q2 		$4.68M Buy
376,312
+90,771
+32% +$1.23M ﹤0.01% 881
2023
Q1 		$4M Buy
285,541
+111,120
+64% +$1.6M ﹤0.01% 946
2022
Q4 		$2.5M Sell
174,421
-200,253
-53% -$3.15M ﹤0.01% 1043
2022
Q3 		$9.57M Buy
374,674
+204,673
+120% +$5.14M ﹤0.01% 832
2022
Q2 		$4.83M Buy
170,001
+15,236
+10% +$483K ﹤0.01% 849
2022
Q1 		$5.46M Sell
154,765
-42,997
-22% -$1.44M ﹤0.01% 999
2021
Q4 		$8.29M Sell
197,762
-149,481
-43% -$6.06M ﹤0.01% 944
2021
Q3 		$17M Buy
347,243
+162,711
+88% +$7.94M 0.01% 825
2021
Q2 		$7.7M Buy
+184,532
New +$7.15M ﹤0.01% 978
2021
Q1 		– Sell
-820,275
Closed -$23M – 1606
2020
Q4 		$23M Buy
+820,275
New +$22.8M 0.01% 724

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Janus Henderson Group's MRVI Position: Q2 2025 in Review

Janus Henderson Group sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 48,498 shares — an estimated $114K sold.

Janus Henderson Group first reported a position in MRVI in Q4 2020 and held it in 17 quarters. The position peaked at $23M in Q4 2020. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

  • Janus Henderson Group reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Janus Henderson Group sold 48,498 Maravai LifeSciences shares in Q2 2025, an estimated $114K.
  • Janus Henderson Group first reported a position in Maravai LifeSciences in Q4 2020 and held it in 17 quarters.
  • Janus Henderson Group's Maravai LifeSciences position peaked at $23M in Q4 2020.
  • 150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on Janus Henderson Group's 13F filing for Q2 2025, filed 14 Aug 2025.